↓ Skip to main content

Dove Medical Press

Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical Trial

Overview of attention for article published in International Journal of General Medicine, June 2021
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#7 of 1,670)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news
52 news outlets
twitter
216 X users
patent
1 patent
facebook
2 Facebook pages
wikipedia
1 Wikipedia page
video
8 YouTube creators

Citations

dimensions_citation
124 Dimensions

Readers on

mendeley
146 Mendeley
Title
Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical Trial
Published in
International Journal of General Medicine, June 2021
DOI 10.2147/ijgm.s318949
Pubmed ID
Authors

Francesco Di Pierro, Somia Iqtadar, Amjad Khan, Sami Ullah Mumtaz, Mohsin Masud Chaudhry, Alexander Bertuccioli, Giuseppe Derosa, Pamela Maffioli, Stefano Togni, Antonella Riva, Pietro Allegrini, Saeed Khan

X Demographics

X Demographics

The data shown below were collected from the profiles of 216 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 146 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 146 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 16 11%
Student > Master 15 10%
Researcher 11 8%
Student > Ph. D. Student 11 8%
Lecturer 4 3%
Other 13 9%
Unknown 76 52%
Readers by discipline Count As %
Medicine and Dentistry 13 9%
Biochemistry, Genetics and Molecular Biology 12 8%
Agricultural and Biological Sciences 8 5%
Chemistry 7 5%
Pharmacology, Toxicology and Pharmaceutical Science 6 4%
Other 21 14%
Unknown 79 54%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 572. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 March 2024.
All research outputs
#42,172
of 25,840,929 outputs
Outputs from International Journal of General Medicine
#7
of 1,670 outputs
Outputs of similar age
#1,483
of 462,484 outputs
Outputs of similar age from International Journal of General Medicine
#2
of 132 outputs
Altmetric has tracked 25,840,929 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,670 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.0. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 462,484 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 132 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.